Bridgebio Oncology Therapeutics, Inc. (BBOT) — what the price could be worth

What Bridgebio Oncology Therapeutics, Inc. could be worth

Bull, base and bear scenarios, opening on what this business has actually done — its realised growth rates and its own P/E range, not round numbers we chose.

Projections are part of Pro

Set the growth, margin and multiple yourself and watch the price land where your assumptions put it — for Bridgebio Oncology Therapeutics, Inc. and every other company we cover.

Bull, base and bear side by side
Defaults from the company’s own record
Its own P/E quartiles, not a guess
Three, five or ten years out

See Pro

Try it first on NVDA, AAPL, META, NKE or CAKE, where it is open to everyone.

What Bridgebio Oncology Therapeutics, Inc. could be worth

What Bridgebio Oncology Therapeutics, Inc. could be worth

Bridgebio Oncology Therapeutics, Inc.

Past performance